https://www.bloomberg.com/opinion/articles/2020-12-31/ark-s-cathie-wood-bets-on-dna-innovators
2 Likes
Do you know you recommended TDOC in 2017 and I was laughing at it. Have I bought, I didnât just like I didnât buy TSLA. Also didnât hold SHOP, TWLO and SQ for long enough. Whoever say donât follow a stranger in the web has to change his attitude, perhaps this forum is different because is visited by many high IQ SWEs?
Cathie is older than us!
Btw, I reserve $200k to pounce into TQQQ or SOXL when the market crash⌠still waiting⌠like a crocodile⌠meanwhile nibbling here and there⌠Refer to the chart below, is worth waiting for the crash⌠the return is SUPER⌠hehe⌠I have already done this comparison long ago 
2 Likes
Even now you are missing MRNA and BNTX . It is supposed to be buy and hold for long years.
The simple reason is these two companies made innovation in medical sciences against world wide deadly diseases.
They have long growth for the years to come.
Perhaps, you will regret, after 5 years , for not buying/holding! 
1 Like
NVAX is also a very HOT stock. While browsing MRNA, REGN, ⌠noted many YouTube videos pumping NVAX.
I do not go behind lame duck nvax!
1 Like
She has been selling TWST. She knows.
1 Like
Bot 100 TWST. So far VRTX is doing well. REGN is screwed despite good result.
TWST up pre-market, do not trade as you may not see this price again, hold long. Company SFO based, 7.68B market cap, very small and have long growth aspects.
1 Like
I FOMOed 50 instead. Green now.
1 Like
Below is the REGN chart with forecasted EW targets, dare you to action on them at your own risk ofc.
Primary count is REGN has completed or about to complete Intermediate degree wave ii, about to launch the wave iii rocket, target ~$674 (price range is $671-$680).
No alternative counts are presented since you considered them as confusing and useless. Use your own stop loss prices if you take up the challenge at your own risk ofc.
1 Like
I see next stop is around $617, but not $674. How do you arrive $674?
Second, what is the next stop of AMRS? https://finviz.com/quote.ashx?t=AMRS
Is it $22.65?
| AMRS | 30-Nov-20 | 2.92 | ||
|---|---|---|---|---|
| AMRS | 19-Jan-21 | 11.35 | ||
| AMRS | 27-Jan-21 | 9.02 | ||
| AMRS | 9-Feb-21 | 15.33 | 22.65974?? |
I use length of wave iii = 2.0 (not equal to) of length of wave I.
Valid ratio is 1, 1.618, 2, 2.618âŚ
So wave iii = 490.02 + 2 * (558.91-467) = $674.
Wave iii could have divided waves, so the ânext stopâ could be lower, I was computing the likely target of wave iii and not computing the ânext stopâ.
1 Like
AMRS is going crazy from $2 to $16 as of now, company is too small 3.5B level, looks like made a break through (claiming) that pulls up to 10B level, hoping (It may also be hype).
If Whatever they said is true, then it may be 3x to 5x level possibilities.
The global acne treatment market was valued at approximately $11 billion in 2019 according to Allied Market Research. North America accounted for the largest share of revenue in 2019. With China as the biggest market, Asia-Pacific is expected to register the highest growth globally over the next five years. Acne or acne vulgaris is one of the most common skin conditions, affecting up to 50 million Americans annually, including approximately 85 percent of people between the ages of 12 and 24. In addition, due to the wearing of face masks to protect against COVID-19 infection, the incidence of âmaskneâ-related acne has been rising. Maskne is a skin condition caused by wearing a face mask or other covering, symptoms of which can include acne around the nose, cheeks, mouth and chin.
Otherwise, it is risk.
3 Likes
Didnât do any EWA on AMRS 
However, notice your favorite concubine genomics stock, CRSP, might be ripe for the picking. Havenât gone deep enough to find out which Cycle degree did wave 5.v.(5) completed. May be over the weekend Look tempting at this price.
Wave 5 is extended, so unlikely to drop all the way to wave 4. More likely here or at wave iv ~$145
I agree , It is a good buy nowâŚ
